Edition:
United Kingdom

Aetna Inc (AET.N)

AET.N on New York Stock Exchange

205.24USD
4:23pm BST
Change (% chg)

$0.04 (+0.02%)
Prev Close
$205.20
Open
$206.00
Day's High
$206.00
Day's Low
$204.58
Volume
437,925
Avg. Vol
464,593
52-wk High
$206.63
52-wk Low
$149.80

Chart for

About

Aetna Inc. is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health,... (more)

Overall

Beta: 0.58
Market Cap(Mil.): $53,561.09
Shares Outstanding(Mil.): 332.10
Dividend: 0.50
Yield (%): 1.24

Financials

  AET.N Industry Sector
P/E (TTM): 35.17 23.95 32.76
EPS (TTM): 4.59 -- --
ROI: -- -0.02 14.61
ROE: 9.45 16.40 16.33

Cigna deal gets antitrust nod, positive sign for CVS-Aetna

Health insurer Cigna Corp's $52 billion acquisition of pharmacy benefits manager Express Scripts Holding Co has passed U.S. antitrust scrutiny, the companies said on Monday, allowing them to proceed with a combination they say will lead to lower costs by better coordinating pharmacy and medical benefits.

17 Sep 2018

U.S. review of CVS deal for Aetna may end soon: source

WASHINGTON The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.

17 Sep 2018

U.S. review of CVS deal for Aetna may end soon -source

WASHINGTON, Sept 17 The U.S. Justice Department's antitrust review of CVS Health Corp's planned purchase of Aetna Inc may conclude soon, a source familiar with the review said on Monday.

17 Sep 2018

L.A. judge tosses Aetna suit against plaintiffs' firms

Aetna’s quest to pin the blame on someone else for exposing the HIV status of thousands of its health insurance customers ran into a cul-de-sac on Friday. Los Angeles Superior Court Judge Richard Rico dismissed Aetna’s case against Whatley Kallas and Consumer Watchdog, holding that the insurer’s claims failed under California’s anti-SLAPP prohibition on suits intended to silence or intimidate critics. Aetna still has a parallel suit against the plaintiffs' firms under way in federal

10 Sep 2018

J&J to work with India on compensation for recalled hip implants

MUMBAI Johnson & Johnson (J&J) said it would work with the Indian government to compensate patients who had suffered from hip implants that were recalled by the U.S. healthcare firm eight years ago after data showed high failure rates.

07 Sep 2018

American Medical Association opposes merger of CVS and Aetna

WASHINGTON The American Medical Association, which represents U.S. physicians, urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna Inc, saying the deal could result in higher prices for prescription medicines.

08 Aug 2018

U.S. doctor's group opposes merger of CVS and Aetna

WASHINGTON, Aug 8 The American Medical Association, which represents U.S. physicians, urged the U.S. Justice Department on Wednesday to stop CVS Health Corp's plan to buy insurance provider Aetna Inc, saying the deal could result in higher prices for prescription medicines.

08 Aug 2018

CVS Health beats profit estimates, defends PBM business

CVS Health Corp beat analysts' estimates for quarterly profit on Wednesday and the drugstore operator defended its pharmacy benefits management business in the face of the Trump administration's move to clamp down on escalating drug costs.

08 Aug 2018

UPDATE 3-CVS Health beats profit estimates, defends PBM business

* Shares up about 4 percent (Adds details from conference call, updates share price)

08 Aug 2018

CVS Health posts quarterly loss on $3.9 bln charge

Aug 8 CVS Health Corp reported a quarterly loss compared with a year-ago profit on Wednesday, as the drugstore retailer took an impairment charge.

08 Aug 2018

Competitors

  Price Chg
Anthem Inc (ANTM.N) $274.36 +0.24
CIGNA Corporation (CI.N) $201.30 -0.03

Earnings vs. Estimates